1997
DOI: 10.1007/bf01728317
|View full text |Cite
|
Sign up to set email alerts
|

99mTc-MIBI uptake in metastatic renal cell carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 2 publications
0
1
0
Order By: Relevance
“…Unexpected detection of malignancies during imaging studies using 99m Tc sestamibi, either parathyroid scintigraphy or myocardial perfusion study, has been reported many times before. However, most of the lesions in prior publications were soft tissue tumors, including those in the thyroid, 6,7 lungs, 8,9 breast, 10–12 mediastinum, 12–14 kidney, 15 and liver 16 . Multiple myeloma can also have elevated sestamibi activity 17,18 .…”
mentioning
confidence: 99%
“…Unexpected detection of malignancies during imaging studies using 99m Tc sestamibi, either parathyroid scintigraphy or myocardial perfusion study, has been reported many times before. However, most of the lesions in prior publications were soft tissue tumors, including those in the thyroid, 6,7 lungs, 8,9 breast, 10–12 mediastinum, 12–14 kidney, 15 and liver 16 . Multiple myeloma can also have elevated sestamibi activity 17,18 .…”
mentioning
confidence: 99%